(Q35805634)

10 August 2017

Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis (English)

1 reference

10 August 2017

0 references

1 reference

1 reference

1 reference

7

R A Kyle

1 reference

10 August 2017

A E Warrington

1

1 reference

10 August 2017

K Asakura

2

1 reference

10 August 2017

A J Bieber

3

1 reference

10 August 2017

B Ciric

4

1 reference

10 August 2017

V Van Keulen

5

1 reference

10 August 2017

S V Kaveri

6

1 reference

10 August 2017

L R Pease

8

1 reference

10 August 2017

M Rodriguez

9

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

10 August 2017

6

1 reference

Proceedings of the National Academy of Sciences of the United States of America

inferred from page(s)

published in

1 reference

10 August 2017

97

1 reference

10 August 2017

6820-6825

1 reference

10 August 2017

12

1 reference

Quantitation of spinal cord demyelination, remyelination, atrophy, and axonal loss in a model of progressive neurologic injury

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Mechanisms of high-dose intravenous immunoglobulins in demyelinating diseases

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Targeting of IgMkappa antibodies to oligodendrocytes promotes CNS remyelination.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

FGF-2 converts mature oligodendrocytes to a novel phenotype

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Effects of transforming growth factor-beta and platelet-derived growth factor on oligodendrocyte precursors: insights gained from a neuronal cell line.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Oligodendrocyte precursors survive poorly and do not migrate following transplantation into the normal adult central nervous system

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Transplanted CG4 cells (an oligodendrocyte progenitor cell line) survive, migrate, and contribute to repair of areas of demyelination in X-irradiated and damaged spinal cord but not in normal spinal cord

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Differential myelinogenic capacity of specific developmental stages of the oligodendrocyte lineage upon transplantation into hypomyelinating hosts

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Experimental strategies to promote central nervous system remyelination in multiple sclerosis: insights gained from the Theiler's virus model system

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Persistent infection of oligodendrocytes in Theiler's virus‐induced encephalomyelitis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Electron microscopic features of multiple sclerosis lesions

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

The spectrum of IgM monoclonal gammopathy in 430 cases

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Identification of an adult-specific glial progenitor cell.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Reversible inhibition of oligodendrocyte progenitor differentiation by a monoclonal antibody against surface galactolipids

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membrane

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

FGF modulates the PDGF-driven pathway of oligodendrocyte development.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Glycolipids and transmembrane signaling: antibodies to galactocerebroside cause an influx of calcium in oligodendrocytes

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

O-2A glial progenitors from mature brain respond to CNS neuronal cell line-derived growth factors

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Manipulating the Immune System with Immune Globulin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Anti-reovirus receptor antibody accelerates expression of the optic nerve oligodendrocyte developmental program

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Pre-oligodendrocytes from adult human CNS

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Open controlled therapeutic trial of intravenous immune globulin in relapsing-remitting multiple sclerosis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Multiple sclerosis. Animal model:Theiler's virus infection in mice

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Survival and differentiation of oligodendrocytes from neural tissue transplanted into new-born mouse brain

27 July 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.12.6820

Behavioural consequences of oligodendrocyte progenitor cell transplantation into experimental demyelinating lesions in the rat spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.12.6820

Monoclonal autoantibody SCH94.03, which promotes central nervous system remyelination, recognizes an antigen on the surface of oligodendrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.12.6820

Polyclonal immunoglobulins for intravenous use do not influence the behaviour of cultured oligodendrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.12.6820

Negative regulation of oligodendrocyte differentiation by galactosphingolipids.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Acceleration in the rate of CNS remyelination in lysolecithin-induced demyelination.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Oligodendrocyte progenitors isolated directly from developing telencephalon at a specific phenotypic stage: myelinogenic potential in a defined environment.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=18751

Repair of demyelinated lesions by transplantation of purified 0-2A progenitor cells

25 September 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.12.6820

Remyelination in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.12.6820

Regenerative potential of adult O1+ oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.12.6820

Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.12.6820

Failure of treatment with Linomide or oral myelin tolerization to ameliorate demyelination in a viral model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.12.6820

Successful treatment of established relapsing experimental autoimmune encephalomyelitis in mice with a monoclonal natural autoantibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.12.6820

Remyelination in the spinal cord of the cat following intraspinal injections of lysolecithin

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.12.6820

Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.12.6820

A shift in encephalitogenic T cell cytokine pattern is associated with suppression of EAE by intravenous immunoglobulins (IVIg)

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.12.6820

Normal human immunoglobulin suppresses experimental myasthenia gravis in SCID mice

21 January 2018

2 references

https://api.crossref.org/works/10.1073%2FPNAS.97.12.6820

21 January 2018

12 December 2020

Analysis of antibody reactivities toward self antigens of IgM of patients with Waldenström's macroglobulinemia

1 reference

PubMed

12 December 2020

Pooled normal human polyspecific IgM contains neutralizing anti-idiotypes to IgG autoantibodies of autoimmune patients and protects from experimental autoimmune disease

1 reference

PubMed

12 December 2020

Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis

1 reference

PubMed

12 December 2020

Identifiers

DOI

10.1073/PNAS.97.12.6820

1 reference

10 August 2017

0 references

1 reference

10 August 2017

1 reference